(494298, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494299, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494300, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494301, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494302, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494303, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494304, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494305, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494306, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494307, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494308, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494309, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494310, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494311, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494312, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494313, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494314, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494315, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494316, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494317, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494318, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494319, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494320, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494321, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494322, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494323, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494324, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494325, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494326, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494327, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494328, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494329, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494330, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494331, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494332, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494333, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494334, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494335, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494336, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494337, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494338, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494339, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494340, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494341, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494342, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494343, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494344, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494345, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494346, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494347, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494348, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494349, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494350, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494351, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494352, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494353, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494354, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494355, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494356, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494357, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494358, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494359, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494360, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494361, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494362, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494363, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494364, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494365, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494366, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494367, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494368, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494369, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494370, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494371, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494372, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494373, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494374, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494375, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494376, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494377, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494378, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494379, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494380, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494381, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494382, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494383, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494384, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494385, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494386, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494387, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494388, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494389, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494390, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494391, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494392, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494393, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494394, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494395, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494396, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494397, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494398, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494399, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494400, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494401, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494402, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494403, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494404, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494405, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494406, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494407, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494408, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494409, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494410, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494411, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494412, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494413, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494414, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494415, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494416, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494417, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494418, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494419, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494420, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494421, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494422, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494423, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494424, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494425, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494426, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494427, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494428, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494429, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494430, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494431, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494432, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494433, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494434, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494435, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494436, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494437, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494438, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494439, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494440, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494441, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494442, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494443, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494444, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494445, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494446, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494447, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494448, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494449, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494450, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494451, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494452, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494453, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494454, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494455, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494456, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494457, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494458, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494459, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494460, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494461, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494462, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494463, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494464, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494465, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494466, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494467, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494468, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494469, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494470, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494471, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494472, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494473, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494474, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494475, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494476, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494477, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494478, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494479, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494480, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494481, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494482, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494483, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494484, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494485, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494486, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494487, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494488, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494489, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494490, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494491, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494492, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494493, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494494, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494495, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494496, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494497, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494498, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494499, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494500, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494501, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494502, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494503, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494504, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494505, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494506, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494507, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494508, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494509, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494510, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494511, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494512, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494513, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494514, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494515, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494516, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494517, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494518, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494519, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494520, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494521, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494522, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494523, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494524, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494525, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494526, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494527, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494528, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494529, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494530, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494531, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494532, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494533, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494534, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494535, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494536, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494537, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494538, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494539, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494540, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494541, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494542, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494543, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494544, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494545, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494546, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494547, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494548, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494549, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494550, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494551, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494552, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494553, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494554, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494555, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494556, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494557, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494558, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494559, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494560, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494561, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494562, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494563, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494564, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494565, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494566, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494567, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494568, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494569, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494570, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494571, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494572, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494573, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494574, 'HP:0034177', 'Reduced circulating interleukin 17A concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(494575, 'HP:0034280', 'Target cells', 'MP:0005641', 'increased mean corpuscular hemoglobin concentration', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494576, 'HP:0034280', 'Target cells', 'MP:0012380', 'decreased erythrocyte sodium ion content', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494577, 'HP:0034280', 'Target cells', 'MP:0010068', 'decreased red blood cell distribution width', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494578, 'HP:0034280', 'Target cells', 'MP:0010176', 'dacryocytosis', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494579, 'HP:0034280', 'Target cells', 'MP:0000314', 'schistocytosis', 0.5384615384615384, 13.66854781257542, 2.7129296496028896, 'UPHENO:0088356', 'shape erythrocyte'),
(494580, 'HP:0034280', 'Target cells', 'MP:0012379', 'abnormal erythrocyte sodium ion content', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494581, 'HP:0034280', 'Target cells', 'MP:0012377', 'decreased erythrocyte potassium ion content', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494582, 'HP:0034280', 'Target cells', 'MP:0010175', 'leptocytosis', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494583, 'HP:0034280', 'Target cells', 'MP:0000256', 'echinocytosis', 0.509090909090909, 13.66854781257542, 2.6379032264009568, 'UPHENO:0088356', 'shape erythrocyte'),
(494584, 'HP:0034280', 'Target cells', 'MP:0003405', 'abnormal platelet shape', 0.41509433962264153, 9.944182255188846, 2.031692340465161, 'UPHENO:0077197', 'abnormal shape of cell'),
(494585, 'HP:0034280', 'Target cells', 'MP:0012373', 'abnormal erythrocyte magnesium ion content', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494586, 'HP:0034280', 'Target cells', 'MP:0010067', 'increased red blood cell distribution width', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494587, 'HP:0034280', 'Target cells', 'MP:0002641', 'anisopoikilocytosis', 0.40350877192982454, 11.346619717688057, 2.1397337656444644, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494588, 'HP:0034280', 'Target cells', 'MP:0012397', 'abnormal nucleated erythrocyte cell number', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494589, 'HP:0034280', 'Target cells', 'MP:0009395', 'increased nucleated erythrocyte cell number', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494590, 'HP:0034280', 'Target cells', 'MP:0012374', 'decreased erythrocyte magnesium ion content', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494591, 'HP:0034280', 'Target cells', 'MP:0002596', 'abnormal hematocrit', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494592, 'HP:0034280', 'Target cells', 'MP:0012376', 'abnormal erythrocyte potassium ion content', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494593, 'HP:0034280', 'Target cells', 'MP:0002642', 'anisocytosis', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494594, 'HP:0034280', 'Target cells', 'MP:0002643', 'poikilocytosis', 0.5490196078431373, 13.66854781257542, 2.739397882718998, 'UPHENO:0005987', 'abnormal shape of erythrocyte'),
(494595, 'HP:0034280', 'Target cells', 'MP:0009547', 'elliptocytosis', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494596, 'HP:0034280', 'Target cells', 'MP:0002812', 'spherocytosis', 0.49122807017543857, 13.66854781257542, 2.5912109840906696, 'UPHENO:0005987', 'abnormal shape of erythrocyte'),
(494597, 'HP:0034280', 'Target cells', 'MP:0005642', 'decreased mean corpuscular hemoglobin concentration', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494598, 'HP:0034280', 'Target cells', 'MP:0012375', 'increased erythrocyte magnesium ion content', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494599, 'HP:0034280', 'Target cells', 'MP:0002447', 'abnormal erythrocyte morphology', 0.46, 11.346619717688057, 2.284610485429958, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494600, 'HP:0034280', 'Target cells', 'MP:0010696', 'increased siderocyte number', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494601, 'HP:0034280', 'Target cells', 'MP:0002814', 'hyperchromasia', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494602, 'HP:0034280', 'Target cells', 'MP:0012398', 'decreased nucleated erythrocyte cell number', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494603, 'HP:0034280', 'Target cells', 'MP:0012372', 'abnormal erythrocyte ion content', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494604, 'HP:0034280', 'Target cells', 'MP:0011240', 'abnormal fetal derived definitive erythrocyte morphology', 0.4107142857142857, 11.346619717688057, 2.158753995392222, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494605, 'HP:0034280', 'Target cells', 'MP:0010177', 'acanthocytosis', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494606, 'HP:0034280', 'Target cells', 'MP:0012381', 'increased erythrocyte sodium ion content', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494607, 'HP:0034280', 'Target cells', 'MP:0005097', 'polychromatophilia', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494608, 'HP:0034280', 'Target cells', 'MP:0002608', 'increased hematocrit', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494609, 'HP:0034280', 'Target cells', 'MP:0011171', 'increased number of Heinz bodies', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494610, 'HP:0034280', 'Target cells', 'MP:0012378', 'increased erythrocyte potassium ion content', 0.4339622641509434, 11.346619717688057, 2.219009865491284, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494611, 'HP:0034280', 'Target cells', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.40425531914893614, 11.083585311854263, 2.1167423833707555, 'UPHENO:0085069', 'abnormal erythroid lineage cell morphology'),
(494612, 'HP:0034280', 'Target cells', 'MP:0010074', 'stomatocytosis', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494613, 'HP:0034280', 'Target cells', 'MP:0001588', 'abnormal hemoglobin', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494614, 'HP:0034280', 'Target cells', 'MP:0010178', 'increased number of Howell-Jolly bodies', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494615, 'HP:0034280', 'Target cells', 'MP:0009568', 'abnormal red blood cell deformability', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494616, 'HP:0034280', 'Target cells', 'MP:0005640', 'abnormal mean corpuscular hemoglobin concentration', 0.4423076923076923, 11.346619717688057, 2.240244893493469, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494617, 'HP:0034280', 'Target cells', 'MP:0010066', 'abnormal red blood cell distribution width', 0.45098039215686275, 11.346619717688057, 2.2621014588072197, 'UPHENO:0084985', 'abnormal erythrocyte morphology'),
(494618, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0001268', 'barrel chest', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494619, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0008736', 'micromelia', 0.4146341463414634, 6.0128226639864275, 1.5789621883961047, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(494620, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0013328', 'visceromegaly', 0.4444444444444444, 5.9605885577567275, 1.6276211076642195, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494621, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0010926', 'increased osteoid volume', 0.40476190476190477, 10.365561281341517, 2.0483125562672417, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(494622, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0031094', 'organomegaly', 0.47058823529411764, 5.9605885577567275, 1.6748083026749803, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494623, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0004556', 'enlarged allantois', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494624, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0010944', 'respiratory epithelium hypertrophy', 0.45, 10.843381614401354, 2.2089639486602333, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(494625, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0002772', 'brachypodia', 0.4318181818181818, 7.3759260872000905, 1.7846733572841949, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(494626, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0001264', 'increased body size', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494627, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0012160', 'expanded anterior visceral endoderm', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494628, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0008772', 'increased heart ventricle size', 0.4186046511627907, 10.843381614401354, 2.1305140173492165, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(494629, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0010875', 'increased bone volume', 0.4358974358974359, 10.365561281341517, 2.125634395698025, 'UPHENO:0084715', 'abnormally increased volume of anatomical entity'),
(494630, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0000547', 'short limbs', 0.425, 6.0128226639864275, 1.5985773776061738, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(494631, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0006296', 'arachnodactyly', 0.4418604651162791, 6.0128226639864275, 1.6299781038316885, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(494632, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0020242', 'enlarged paws', 0.5135135135135135, 6.0128226639864275, 1.757175487057953, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(494633, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0000573', 'enlarged hind paws', 0.5121951219512195, 7.3759260872000905, 1.943685509987825, 'UPHENO:0084767', 'abnormal anatomical entity morphology in the pelvic complex'),
(494634, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0001267', 'enlarged chest', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494635, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0008725', 'enlarged heart atrium', 0.4186046511627907, 10.843381614401354, 2.1305140173492165, 'UPHENO:0084489', 'hypertrophic multicellular anatomical structure'),
(494636, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0000548', 'long limbs', 0.5, 6.0128226639864275, 1.7339006119132705, 'UPHENO:0084763', 'abnormal anatomical entity morphology in the appendage girdle complex'),
(494637, 'HP:0010496', 'Hypertrophy of the lower limb', 'MP:0000588', 'thick tail', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(494638, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002308', 'abnormal residual volume', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(494639, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002306', 'abnormal functional residual capacity', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(494640, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0005585', 'increased tidal volume', 0.40816326530612246, 9.915985363358194, 2.0118004286300364, 'UPHENO:0019970', 'abnormal lung morphology'),
(494641, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002337', 'abnormal whole-body plethysmography', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(494642, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002313', 'abnormal tidal volume', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(494643, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0001942', 'abnormal lung volume', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(494644, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002311', 'abnormal inspiratory capacity', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(494645, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002309', 'abnormal vital capacity', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(494646, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(494647, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0002304', 'abnormal total lung capacity', 0.40816326530612246, 9.915985363358194, 2.0118004286300364, 'UPHENO:0019970', 'abnormal lung morphology'),
(494648, 'HP:0006529', 'Abnormal pulmonary lymphatics', 'MP:0005586', 'decreased tidal volume', 0.40816326530612246, 9.915985363358194, 2.0118004286300364, 'UPHENO:0019970', 'abnormal lung morphology'),
(494649, 'HP:0012779', 'Transient hearing impairment', 'MP:0001967', 'deafness', 0.5952380952380952, 12.464189314069232, 2.7238135593306656, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494650, 'HP:0012779', 'Transient hearing impairment', 'MP:0004749', 'nonsyndromic hearing loss', 0.6097560975609756, 12.464189314069232, 2.7568306867502885, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494651, 'HP:0012779', 'Transient hearing impairment', 'MP:0001963', 'abnormal hearing physiology', 0.42105263157894735, 10.87018167374507, 2.139373412817783, 'UPHENO:0002240', 'abnormality of ear physiology'),
(494652, 'HP:0012779', 'Transient hearing impairment', 'MP:0006325', 'impaired hearing', 0.6410256410256411, 12.464189314069232, 2.826634915392537, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494653, 'HP:0012779', 'Transient hearing impairment', 'MP:0003878', 'abnormal ear physiology', 0.43243243243243246, 10.87018167374507, 2.1680911194320296, 'UPHENO:0002240', 'abnormality of ear physiology'),
(494654, 'HP:0012779', 'Transient hearing impairment', 'MP:0006330', 'syndromic hearing impairment', 0.625, 12.464189314069232, 2.7910783438114506, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494655, 'HP:0012779', 'Transient hearing impairment', 'MP:0004739', 'conductive hearing loss', 0.6097560975609756, 12.464189314069232, 2.7568306867502885, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494656, 'HP:0012779', 'Transient hearing impairment', 'MP:0004750', 'syndromic hearing loss', 0.6097560975609756, 12.464189314069232, 2.7568306867502885, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494657, 'HP:0012779', 'Transient hearing impairment', 'MP:0004741', 'mixed hearing loss', 0.6097560975609756, 12.464189314069232, 2.7568306867502885, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494658, 'HP:0012779', 'Transient hearing impairment', 'MP:0004742', 'abnormal vestibular system physiology', 0.41025641025641024, 10.87018167374507, 2.1117674380257094, 'UPHENO:0002240', 'abnormality of ear physiology'),
(494659, 'HP:0012779', 'Transient hearing impairment', 'MP:0006326', 'conductive hearing impairment', 0.625, 12.464189314069232, 2.7910783438114506, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494660, 'HP:0012779', 'Transient hearing impairment', 'MP:0006329', 'sensorineural hearing impairment', 0.625, 12.464189314069232, 2.7910783438114506, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494661, 'HP:0012779', 'Transient hearing impairment', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41025641025641024, 10.87018167374507, 2.1117674380257094, 'UPHENO:0002240', 'abnormality of ear physiology'),
(494662, 'HP:0012779', 'Transient hearing impairment', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41025641025641024, 10.87018167374507, 2.1117674380257094, 'UPHENO:0002240', 'abnormality of ear physiology'),
(494663, 'HP:0012779', 'Transient hearing impairment', 'MP:0003741', 'tinnitus', 0.41025641025641024, 10.87018167374507, 2.1117674380257094, 'UPHENO:0002240', 'abnormality of ear physiology'),
(494664, 'HP:0012779', 'Transient hearing impairment', 'MP:0006336', 'abnormal otoacoustic response', 0.41025641025641024, 10.87018167374507, 2.1117674380257094, 'UPHENO:0002240', 'abnormality of ear physiology'),
(494665, 'HP:0012779', 'Transient hearing impairment', 'MP:0006327', 'mixed hearing impairment', 0.625, 12.464189314069232, 2.7910783438114506, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494666, 'HP:0012779', 'Transient hearing impairment', 'MP:0006328', 'nonsyndromic hearing impairment', 0.625, 12.464189314069232, 2.7910783438114506, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494667, 'HP:0012779', 'Transient hearing impairment', 'MP:0004699', 'unilateral deafness', 0.625, 12.464189314069232, 2.7910783438114506, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494668, 'HP:0012779', 'Transient hearing impairment', 'MP:0004740', 'sensorineural hearing loss', 0.6097560975609756, 12.464189314069232, 2.7568306867502885, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(494669, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494670, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494671, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494672, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494673, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494674, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494675, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494676, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494677, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494678, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494679, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494680, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494681, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494682, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494683, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494684, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494685, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494686, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494687, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494688, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494689, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494690, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494691, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494692, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494693, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494694, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494695, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494696, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494697, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494698, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494699, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494700, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494701, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494702, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494703, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494704, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494705, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494706, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494707, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494708, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494709, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494710, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494711, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494712, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494713, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494714, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494715, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494716, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494717, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494718, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494719, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494720, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494721, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494722, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494723, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494724, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494725, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494726, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494727, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494728, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494729, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494730, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494731, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494732, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494733, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494734, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494735, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494736, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494737, 'HP:0012011', 'EEG with occipital focal spike waves', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494738, 'HP:0011763', 'Pituitary carcinoma', 'MP:0008936', 'abnormal pituitary gland size', 0.42857142857142855, 10.291242960651683, 2.100126828889662, 'UPHENO:0087940', 'abnormal pituitary gland morphology'),
(494739, 'HP:0011763', 'Pituitary carcinoma', 'MP:0000636', 'enlarged pituitary gland', 0.40298507462686567, 10.291242960651683, 2.036471780433361, 'UPHENO:0087940', 'abnormal pituitary gland morphology'),
(494740, 'HP:0011763', 'Pituitary carcinoma', 'MP:0008366', 'enlarged adenohypophysis', 0.417910447761194, 10.457400148406593, 2.0905159120271186, 'UPHENO:0075772', 'abnormal adenohypophysis'),
(494741, 'HP:0011763', 'Pituitary carcinoma', 'MP:0008937', 'abnormal pituitary gland weight', 0.4090909090909091, 10.291242960651683, 2.0518415968218444, 'UPHENO:0087940', 'abnormal pituitary gland morphology'),
(494742, 'HP:0011763', 'Pituitary carcinoma', 'MP:0008368', 'small pituitary intermediate lobe', 0.4057971014492754, 10.457400148406593, 2.059995793422554, 'UPHENO:0075772', 'abnormal adenohypophysis'),
(494743, 'HP:0011763', 'Pituitary carcinoma', 'MP:0005361', 'small pituitary gland', 0.40298507462686567, 10.291242960651683, 2.036471780433361, 'UPHENO:0087940', 'abnormal pituitary gland morphology'),
(494744, 'HP:0011763', 'Pituitary carcinoma', 'MP:0013341', 'abnormal folliculo-stellate cell morphology', 0.4117647058823529, 10.457400148406593, 2.0750875394553154, 'UPHENO:0075772', 'abnormal adenohypophysis'),
(494745, 'HP:0011763', 'Pituitary carcinoma', 'MP:0008370', 'enlarged pituitary intermediate lobe', 0.4057971014492754, 10.457400148406593, 2.059995793422554, 'UPHENO:0075772', 'abnormal adenohypophysis'),
(494746, 'HP:0011763', 'Pituitary carcinoma', 'MP:0008321', 'small adenohypophysis', 0.417910447761194, 10.457400148406593, 2.0905159120271186, 'UPHENO:0075772', 'abnormal adenohypophysis'),
(494747, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494748, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494749, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494750, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494751, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494752, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494753, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494754, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494755, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494756, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494757, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494758, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494759, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494760, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494761, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494762, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494763, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494764, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494765, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494766, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494767, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494768, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494769, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494770, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494771, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494772, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494773, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494774, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494775, 'HP:0032750', 'Focal impaired awareness emotional seizure with laughing', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(494776, 'HP:0032620', 'Intrarenal abscess', 'MP:0003881', 'abnormal nephron morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494777, 'HP:0032620', 'Intrarenal abscess', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494778, 'HP:0032620', 'Intrarenal abscess', 'MP:0003826', 'abnormal Mullerian duct morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494779, 'HP:0032620', 'Intrarenal abscess', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494780, 'HP:0032620', 'Intrarenal abscess', 'MP:0003600', 'ectopic kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494781, 'HP:0032620', 'Intrarenal abscess', 'MP:0008528', 'polycystic kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494782, 'HP:0032620', 'Intrarenal abscess', 'MP:0011487', 'abnormal ureteropelvic junction morphology', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494783, 'HP:0032620', 'Intrarenal abscess', 'MP:0011488', 'abnormal ureterovesical junction morphology', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494784, 'HP:0032620', 'Intrarenal abscess', 'MP:0009641', 'kidney degeneration', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494785, 'HP:0032620', 'Intrarenal abscess', 'MP:0003985', 'renal fibrosis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494786, 'HP:0032620', 'Intrarenal abscess', 'MP:0003942', 'abnormal urinary system development', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494787, 'HP:0032620', 'Intrarenal abscess', 'MP:0008487', 'abnormal mesonephros morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494788, 'HP:0032620', 'Intrarenal abscess', 'MP:0003613', 'abnormal kidney medulla development', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494789, 'HP:0032620', 'Intrarenal abscess', 'MP:0002703', 'abnormal renal tubule morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494790, 'HP:0032620', 'Intrarenal abscess', 'MP:0004755', 'abnormal loop of Henle morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494791, 'HP:0032620', 'Intrarenal abscess', 'MP:0011364', 'abnormal metanephros morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494792, 'HP:0032620', 'Intrarenal abscess', 'MP:0000530', 'abnormal kidney vasculature morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494793, 'HP:0032620', 'Intrarenal abscess', 'MP:0011383', 'abnormal kidney capsule morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494794, 'HP:0032620', 'Intrarenal abscess', 'MP:0011382', 'abnormal kidney lobule morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494795, 'HP:0032620', 'Intrarenal abscess', 'MP:0011381', 'abnormal kidney lobe morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494796, 'HP:0032620', 'Intrarenal abscess', 'MP:0004195', 'abnormal kidney calyx morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494797, 'HP:0032620', 'Intrarenal abscess', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494798, 'HP:0032620', 'Intrarenal abscess', 'MP:0000521', 'abnormal kidney cortex morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494799, 'HP:0032620', 'Intrarenal abscess', 'MP:0005360', 'urolithiasis', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494800, 'HP:0032620', 'Intrarenal abscess', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494801, 'HP:0032620', 'Intrarenal abscess', 'MP:0002708', 'nephrolithiasis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494802, 'HP:0032620', 'Intrarenal abscess', 'MP:0000527', 'abnormal kidney development', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494803, 'HP:0032620', 'Intrarenal abscess', 'MP:0004969', 'pale kidney', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494804, 'HP:0032620', 'Intrarenal abscess', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494805, 'HP:0032620', 'Intrarenal abscess', 'MP:0009860', 'nephrosclerosis', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494806, 'HP:0032620', 'Intrarenal abscess', 'MP:0002955', 'increased compensatory renal growth', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494807, 'HP:0032620', 'Intrarenal abscess', 'MP:0003672', 'abnormal ureter development', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494808, 'HP:0032620', 'Intrarenal abscess', 'MP:0011361', 'pelvic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494809, 'HP:0032620', 'Intrarenal abscess', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494810, 'HP:0032620', 'Intrarenal abscess', 'MP:0003675', 'kidney cyst', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494811, 'HP:0032620', 'Intrarenal abscess', 'MP:0011402', 'renal cast', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494812, 'HP:0032620', 'Intrarenal abscess', 'MP:0011534', 'granular kidney', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494813, 'HP:0032620', 'Intrarenal abscess', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494814, 'HP:0032620', 'Intrarenal abscess', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494815, 'HP:0032620', 'Intrarenal abscess', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494816, 'HP:0032620', 'Intrarenal abscess', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494817, 'HP:0032620', 'Intrarenal abscess', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494818, 'HP:0032620', 'Intrarenal abscess', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494819, 'HP:0032620', 'Intrarenal abscess', 'MP:0000534', 'abnormal ureter morphology', 0.43333333333333335, 7.390401409715969, 1.7895550501573252, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494820, 'HP:0032620', 'Intrarenal abscess', 'MP:0012025', 'abnormal comma shaped body morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494821, 'HP:0032620', 'Intrarenal abscess', 'MP:0002707', 'abnormal kidney weight', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494822, 'HP:0032620', 'Intrarenal abscess', 'MP:0002706', 'abnormal kidney size', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494823, 'HP:0032620', 'Intrarenal abscess', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494824, 'HP:0032620', 'Intrarenal abscess', 'MP:0003197', 'nephrocalcinosis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494825, 'HP:0032620', 'Intrarenal abscess', 'MP:0031002', 'abnormal kidney glycogen level', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494826, 'HP:0032620', 'Intrarenal abscess', 'MP:0011767', 'ureterocele', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494827, 'HP:0032620', 'Intrarenal abscess', 'MP:0011843', 'abnormal kidney collecting duct epithelium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494828, 'HP:0032620', 'Intrarenal abscess', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494829, 'HP:0032620', 'Intrarenal abscess', 'MP:0003014', 'abnormal kidney medulla morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494830, 'HP:0032620', 'Intrarenal abscess', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494831, 'HP:0032620', 'Intrarenal abscess', 'MP:0002956', 'decreased compensatory renal growth', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494832, 'HP:0032620', 'Intrarenal abscess', 'MP:0002135', 'abnormal kidney morphology', 0.5357142857142857, 7.667568053596582, 2.0267278413734213, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494833, 'HP:0032620', 'Intrarenal abscess', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494834, 'HP:0032620', 'Intrarenal abscess', 'MP:0012024', 'abnormal nephron morphogenesis', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494835, 'HP:0032620', 'Intrarenal abscess', 'MP:0003605', 'fused kidneys', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494836, 'HP:0032620', 'Intrarenal abscess', 'MP:0011797', 'blind ureter', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494837, 'HP:0032620', 'Intrarenal abscess', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4444444444444444, 7.390401409715969, 1.8123528488577088, 'UPHENO:0087427', 'abnormal renal system morphology'),
(494838, 'HP:0032620', 'Intrarenal abscess', 'MP:0011331', 'abnormal papillary duct morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494839, 'HP:0032620', 'Intrarenal abscess', 'MP:0012026', 'abnormal S-shaped body morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(494840, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0008820', 'abnormal blood uric acid level', 0.4444444444444444, 8.001050554100775, 1.8857418880878776, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(494841, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0005308', 'abnormal circulating ammonia level', 0.4166666666666667, 8.001050554100775, 1.82586173195252, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(494842, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4166666666666667, 8.001050554100775, 1.82586173195252, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(494843, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4444444444444444, 8.001050554100775, 1.8857418880878776, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(494844, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0005416', 'abnormal circulating protein level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(494845, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0011611', 'abnormal circulating ghrelin level', 0.40816326530612246, 8.001050554100775, 1.8071344499071265, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(494846, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0030757', 'abnormal circulating histamine level', 0.4166666666666667, 8.001050554100775, 1.82586173195252, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(494847, 'HP:0410341', 'Abnormal circulating heparan sulfate level', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4782608695652174, 12.169741955603977, 2.4125321490234004, 'UPHENO:0051657', 'abnormal independent continuant glycosaminoglycan level'),
(494848, 'HP:0003922', 'Spurred humeral metaphysis', 'MP:0004350', 'long humerus', 0.4177215189873418, 11.214829845132515, 2.164411180458401, 'UPHENO:0087565', 'abnormal humerus morphology'),
(494849, 'HP:0003922', 'Spurred humeral metaphysis', 'MP:0004351', 'short humerus', 0.4125, 11.214829845132515, 2.1508410706319427, 'UPHENO:0087565', 'abnormal humerus morphology'),
(494850, 'HP:0031274', 'Hypovolemic shock', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494851, 'HP:0031274', 'Hypovolemic shock', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494852, 'HP:0031274', 'Hypovolemic shock', 'MP:0004878', 'increased systemic vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494853, 'HP:0031274', 'Hypovolemic shock', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494854, 'HP:0031274', 'Hypovolemic shock', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494855, 'HP:0031274', 'Hypovolemic shock', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494856, 'HP:0031274', 'Hypovolemic shock', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494857, 'HP:0031274', 'Hypovolemic shock', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494858, 'HP:0031274', 'Hypovolemic shock', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494859, 'HP:0031274', 'Hypovolemic shock', 'MP:0005595', 'abnormal vascular smooth muscle physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494860, 'HP:0031274', 'Hypovolemic shock', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494861, 'HP:0031274', 'Hypovolemic shock', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494862, 'HP:0031274', 'Hypovolemic shock', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494863, 'HP:0031274', 'Hypovolemic shock', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494864, 'HP:0031274', 'Hypovolemic shock', 'MP:0020001', 'decreased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494865, 'HP:0031274', 'Hypovolemic shock', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494866, 'HP:0031274', 'Hypovolemic shock', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494867, 'HP:0031274', 'Hypovolemic shock', 'MP:0010393', 'shortened QRS complex duration', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494868, 'HP:0031274', 'Hypovolemic shock', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494869, 'HP:0031274', 'Hypovolemic shock', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494870, 'HP:0031274', 'Hypovolemic shock', 'MP:0006053', 'hypothalamus hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494871, 'HP:0031274', 'Hypovolemic shock', 'MP:0002471', 'abnormal complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494872, 'HP:0031274', 'Hypovolemic shock', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494873, 'HP:0031274', 'Hypovolemic shock', 'MP:0003777', 'lip inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494874, 'HP:0031274', 'Hypovolemic shock', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494875, 'HP:0031274', 'Hypovolemic shock', 'MP:0005000', 'abnormal immune tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494876, 'HP:0031274', 'Hypovolemic shock', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494877, 'HP:0031274', 'Hypovolemic shock', 'MP:0010560', 'intraventricular block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494878, 'HP:0031274', 'Hypovolemic shock', 'MP:0012305', 'umbilical cord hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494879, 'HP:0031274', 'Hypovolemic shock', 'MP:0003039', 'increased time of peak ischemic contracture', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494880, 'HP:0031274', 'Hypovolemic shock', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494881, 'HP:0031274', 'Hypovolemic shock', 'MP:0008568', 'abnormal interleukin secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494882, 'HP:0031274', 'Hypovolemic shock', 'MP:0003474', 'abnormal summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494883, 'HP:0031274', 'Hypovolemic shock', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494884, 'HP:0031274', 'Hypovolemic shock', 'MP:0003483', 'decreased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494885, 'HP:0031274', 'Hypovolemic shock', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494886, 'HP:0031274', 'Hypovolemic shock', 'MP:0011926', 'abnormal heart valve physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494887, 'HP:0031274', 'Hypovolemic shock', 'MP:0030153', 'dental pulp inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494888, 'HP:0031274', 'Hypovolemic shock', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494889, 'HP:0031274', 'Hypovolemic shock', 'MP:0031156', 'large intestine hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494890, 'HP:0031274', 'Hypovolemic shock', 'MP:0001835', 'abnormal antigen presentation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494891, 'HP:0031274', 'Hypovolemic shock', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494892, 'HP:0031274', 'Hypovolemic shock', 'MP:0003901', 'abnormal PR interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494893, 'HP:0031274', 'Hypovolemic shock', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494894, 'HP:0031274', 'Hypovolemic shock', 'MP:0006044', 'tricuspid valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494895, 'HP:0031274', 'Hypovolemic shock', 'MP:0031118', 'cardiovalvulitis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494896, 'HP:0031274', 'Hypovolemic shock', 'MP:0010695', 'abnormal blood pressure regulation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494897, 'HP:0031274', 'Hypovolemic shock', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494898, 'HP:0031274', 'Hypovolemic shock', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494899, 'HP:0031274', 'Hypovolemic shock', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494900, 'HP:0031274', 'Hypovolemic shock', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494901, 'HP:0031274', 'Hypovolemic shock', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494902, 'HP:0031274', 'Hypovolemic shock', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494903, 'HP:0031274', 'Hypovolemic shock', 'MP:0003467', 'abnormal single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494904, 'HP:0031274', 'Hypovolemic shock', 'MP:0008008', 'early cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494905, 'HP:0031274', 'Hypovolemic shock', 'MP:0003725', 'increased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494906, 'HP:0031274', 'Hypovolemic shock', 'MP:0005532', 'abnormal vascular resistance', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494907, 'HP:0031274', 'Hypovolemic shock', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494908, 'HP:0031274', 'Hypovolemic shock', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494909, 'HP:0031274', 'Hypovolemic shock', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494910, 'HP:0031274', 'Hypovolemic shock', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494911, 'HP:0031274', 'Hypovolemic shock', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494912, 'HP:0031274', 'Hypovolemic shock', 'MP:0004216', 'salt-resistant hypertension', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494913, 'HP:0031274', 'Hypovolemic shock', 'MP:0003726', 'decreased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494914, 'HP:0031274', 'Hypovolemic shock', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494915, 'HP:0031274', 'Hypovolemic shock', 'MP:0008950', 'ventricular tachycardia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494916, 'HP:0031274', 'Hypovolemic shock', 'MP:0004156', 'abnormal QT variability', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494917, 'HP:0031274', 'Hypovolemic shock', 'MP:0003009', 'abnormal cytokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494918, 'HP:0031274', 'Hypovolemic shock', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494919, 'HP:0031274', 'Hypovolemic shock', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494920, 'HP:0031274', 'Hypovolemic shock', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494921, 'HP:0031274', 'Hypovolemic shock', 'MP:0005330', 'cardiomyopathy', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494922, 'HP:0031274', 'Hypovolemic shock', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494923, 'HP:0031274', 'Hypovolemic shock', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494924, 'HP:0031274', 'Hypovolemic shock', 'MP:0005333', 'decreased heart rate', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494925, 'HP:0031274', 'Hypovolemic shock', 'MP:0013971', 'blood in lymph vessels', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494926, 'HP:0031274', 'Hypovolemic shock', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494927, 'HP:0031274', 'Hypovolemic shock', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494928, 'HP:0031274', 'Hypovolemic shock', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494929, 'HP:0031274', 'Hypovolemic shock', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494930, 'HP:0031274', 'Hypovolemic shock', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494931, 'HP:0031274', 'Hypovolemic shock', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494932, 'HP:0031274', 'Hypovolemic shock', 'MP:0001846', 'increased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494933, 'HP:0031274', 'Hypovolemic shock', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494934, 'HP:0031274', 'Hypovolemic shock', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494935, 'HP:0031274', 'Hypovolemic shock', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494936, 'HP:0031274', 'Hypovolemic shock', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494937, 'HP:0031274', 'Hypovolemic shock', 'MP:0004003', 'abnormal vascular endothelial cell physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494938, 'HP:0031274', 'Hypovolemic shock', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494939, 'HP:0031274', 'Hypovolemic shock', 'MP:0005402', 'abnormal action potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494940, 'HP:0031274', 'Hypovolemic shock', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494941, 'HP:0031274', 'Hypovolemic shock', 'MP:0000947', 'convulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494942, 'HP:0031274', 'Hypovolemic shock', 'MP:0000249', 'abnormal blood vessel physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494943, 'HP:0031274', 'Hypovolemic shock', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494944, 'HP:0031274', 'Hypovolemic shock', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494945, 'HP:0031274', 'Hypovolemic shock', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494946, 'HP:0031274', 'Hypovolemic shock', 'MP:0010553', 'prolonged HV interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494947, 'HP:0031274', 'Hypovolemic shock', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494948, 'HP:0031274', 'Hypovolemic shock', 'MP:0010554', 'shortened HV interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494949, 'HP:0031274', 'Hypovolemic shock', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494950, 'HP:0031274', 'Hypovolemic shock', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494951, 'HP:0031274', 'Hypovolemic shock', 'MP:0004751', 'increased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494952, 'HP:0031274', 'Hypovolemic shock', 'MP:0031128', 'cardiovascular shunt', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494953, 'HP:0031274', 'Hypovolemic shock', 'MP:0010505', 'abnormal T wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494954, 'HP:0031274', 'Hypovolemic shock', 'MP:0010509', 'decreased P wave amplitude', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494955, 'HP:0031274', 'Hypovolemic shock', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494956, 'HP:0031274', 'Hypovolemic shock', 'MP:0011930', 'abnormal tricuspid valve flow', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494957, 'HP:0031274', 'Hypovolemic shock', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494958, 'HP:0031274', 'Hypovolemic shock', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494959, 'HP:0031274', 'Hypovolemic shock', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494960, 'HP:0031274', 'Hypovolemic shock', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494961, 'HP:0031274', 'Hypovolemic shock', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494962, 'HP:0031274', 'Hypovolemic shock', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494963, 'HP:0031274', 'Hypovolemic shock', 'MP:0008817', 'hematoma', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494964, 'HP:0031274', 'Hypovolemic shock', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494965, 'HP:0031274', 'Hypovolemic shock', 'MP:0005599', 'increased cardiac muscle contractility', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494966, 'HP:0031274', 'Hypovolemic shock', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494967, 'HP:0031274', 'Hypovolemic shock', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494968, 'HP:0031274', 'Hypovolemic shock', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494969, 'HP:0031274', 'Hypovolemic shock', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494970, 'HP:0031274', 'Hypovolemic shock', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494971, 'HP:0031274', 'Hypovolemic shock', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494972, 'HP:0031274', 'Hypovolemic shock', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494973, 'HP:0031274', 'Hypovolemic shock', 'MP:0031152', 'subcutaneous hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494974, 'HP:0031274', 'Hypovolemic shock', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494975, 'HP:0031274', 'Hypovolemic shock', 'MP:0013127', 'epistaxis', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494976, 'HP:0031274', 'Hypovolemic shock', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494977, 'HP:0031274', 'Hypovolemic shock', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494978, 'HP:0031274', 'Hypovolemic shock', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494979, 'HP:0031274', 'Hypovolemic shock', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494980, 'HP:0031274', 'Hypovolemic shock', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494981, 'HP:0031274', 'Hypovolemic shock', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494982, 'HP:0031274', 'Hypovolemic shock', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494983, 'HP:0031274', 'Hypovolemic shock', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494984, 'HP:0031274', 'Hypovolemic shock', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494985, 'HP:0031274', 'Hypovolemic shock', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494986, 'HP:0031274', 'Hypovolemic shock', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494987, 'HP:0031274', 'Hypovolemic shock', 'MP:0002635', 'reduced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494988, 'HP:0031274', 'Hypovolemic shock', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494989, 'HP:0031274', 'Hypovolemic shock', 'MP:0001853', 'heart inflammation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494990, 'HP:0031274', 'Hypovolemic shock', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494991, 'HP:0031274', 'Hypovolemic shock', 'MP:0000465', 'gastrointestinal hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494992, 'HP:0031274', 'Hypovolemic shock', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494993, 'HP:0031274', 'Hypovolemic shock', 'MP:0003438', 'abnormal carotid body physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494994, 'HP:0031274', 'Hypovolemic shock', 'MP:0011929', 'abnormal aortic valve flow', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494995, 'HP:0031274', 'Hypovolemic shock', 'MP:0003824', 'decreased left ventricle developed pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494996, 'HP:0031274', 'Hypovolemic shock', 'MP:0005167', 'abnormal blood-brain barrier function', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494997, 'HP:0031274', 'Hypovolemic shock', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(494998, 'HP:0031274', 'Hypovolemic shock', 'MP:0030129', 'tongue inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(494999, 'HP:0031274', 'Hypovolemic shock', 'MP:0008722', 'abnormal chemokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495000, 'HP:0031274', 'Hypovolemic shock', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495001, 'HP:0031274', 'Hypovolemic shock', 'MP:0002500', 'granulomatous inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495002, 'HP:0031274', 'Hypovolemic shock', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495003, 'HP:0031274', 'Hypovolemic shock', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495004, 'HP:0031274', 'Hypovolemic shock', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495005, 'HP:0031274', 'Hypovolemic shock', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495006, 'HP:0031274', 'Hypovolemic shock', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495007, 'HP:0031274', 'Hypovolemic shock', 'MP:0012553', 'decreased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495008, 'HP:0031274', 'Hypovolemic shock', 'MP:0001627', 'abnormal cardiac output', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495009, 'HP:0031274', 'Hypovolemic shock', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495010, 'HP:0031274', 'Hypovolemic shock', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495011, 'HP:0031274', 'Hypovolemic shock', 'MP:0003469', 'decreased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495012, 'HP:0031274', 'Hypovolemic shock', 'MP:0001800', 'abnormal humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495013, 'HP:0031274', 'Hypovolemic shock', 'MP:0010507', 'shortened RR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495014, 'HP:0031274', 'Hypovolemic shock', 'MP:0011514', 'skin hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495015, 'HP:0031274', 'Hypovolemic shock', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495016, 'HP:0031274', 'Hypovolemic shock', 'MP:0006051', 'brainstem hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495017, 'HP:0031274', 'Hypovolemic shock', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495018, 'HP:0031274', 'Hypovolemic shock', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495019, 'HP:0031274', 'Hypovolemic shock', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495020, 'HP:0031274', 'Hypovolemic shock', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495021, 'HP:0031274', 'Hypovolemic shock', 'MP:0020097', 'low mean heart rate adaptation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495022, 'HP:0031274', 'Hypovolemic shock', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495023, 'HP:0031274', 'Hypovolemic shock', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495024, 'HP:0031274', 'Hypovolemic shock', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495025, 'HP:0031274', 'Hypovolemic shock', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495026, 'HP:0031274', 'Hypovolemic shock', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495027, 'HP:0031274', 'Hypovolemic shock', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495028, 'HP:0031274', 'Hypovolemic shock', 'MP:0001599', 'abnormal blood volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495029, 'HP:0031274', 'Hypovolemic shock', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495030, 'HP:0031274', 'Hypovolemic shock', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495031, 'HP:0031274', 'Hypovolemic shock', 'MP:0005087', 'decreased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495032, 'HP:0031274', 'Hypovolemic shock', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495033, 'HP:0031274', 'Hypovolemic shock', 'MP:0003820', 'increased left ventricle systolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495034, 'HP:0031274', 'Hypovolemic shock', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495035, 'HP:0031274', 'Hypovolemic shock', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495036, 'HP:0031274', 'Hypovolemic shock', 'MP:0011918', 'abnormal PQ interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495037, 'HP:0031274', 'Hypovolemic shock', 'MP:0005435', 'hemoperitoneum', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495038, 'HP:0031274', 'Hypovolemic shock', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495039, 'HP:0031274', 'Hypovolemic shock', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495040, 'HP:0031274', 'Hypovolemic shock', 'MP:0006112', 'angina', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495041, 'HP:0031274', 'Hypovolemic shock', 'MP:0006265', 'increased pulse pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495042, 'HP:0031274', 'Hypovolemic shock', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495043, 'HP:0031274', 'Hypovolemic shock', 'MP:0006114', 'cardiac murmur', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495044, 'HP:0031274', 'Hypovolemic shock', 'MP:0003233', 'prolonged QT interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495045, 'HP:0031274', 'Hypovolemic shock', 'MP:0005529', 'abnormal renal vascular resistance', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495046, 'HP:0031274', 'Hypovolemic shock', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495047, 'HP:0031274', 'Hypovolemic shock', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495048, 'HP:0031274', 'Hypovolemic shock', 'MP:0004009', 'abnormal diastolic filling velocity', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495049, 'HP:0031274', 'Hypovolemic shock', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495050, 'HP:0031274', 'Hypovolemic shock', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495051, 'HP:0031274', 'Hypovolemic shock', 'MP:0003762', 'abnormal immune organ physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495052, 'HP:0031274', 'Hypovolemic shock', 'MP:0003547', 'abnormal pulmonary pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495053, 'HP:0031274', 'Hypovolemic shock', 'MP:0012011', 'febrile seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495054, 'HP:0031274', 'Hypovolemic shock', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495055, 'HP:0031274', 'Hypovolemic shock', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495056, 'HP:0031274', 'Hypovolemic shock', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495057, 'HP:0031274', 'Hypovolemic shock', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495058, 'HP:0031274', 'Hypovolemic shock', 'MP:0031170', 'abnormal vasculature physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495059, 'HP:0031274', 'Hypovolemic shock', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495060, 'HP:0031274', 'Hypovolemic shock', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495061, 'HP:0031274', 'Hypovolemic shock', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495062, 'HP:0031274', 'Hypovolemic shock', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495063, 'HP:0031274', 'Hypovolemic shock', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495064, 'HP:0031274', 'Hypovolemic shock', 'MP:0004070', 'abnormal P wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495065, 'HP:0031274', 'Hypovolemic shock', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495066, 'HP:0031274', 'Hypovolemic shock', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495067, 'HP:0031274', 'Hypovolemic shock', 'MP:0005403', 'abnormal nerve conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495068, 'HP:0031274', 'Hypovolemic shock', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495069, 'HP:0031274', 'Hypovolemic shock', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495070, 'HP:0031274', 'Hypovolemic shock', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495071, 'HP:0031274', 'Hypovolemic shock', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495072, 'HP:0031274', 'Hypovolemic shock', 'MP:0005600', 'increased ventricle muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495073, 'HP:0031274', 'Hypovolemic shock', 'MP:0003477', 'abnormal nerve fiber response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495074, 'HP:0031274', 'Hypovolemic shock', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495075, 'HP:0031274', 'Hypovolemic shock', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495076, 'HP:0031274', 'Hypovolemic shock', 'MP:0006109', 'fibrillation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495077, 'HP:0031274', 'Hypovolemic shock', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495078, 'HP:0031274', 'Hypovolemic shock', 'MP:0003394', 'increased cardiac output', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495079, 'HP:0031274', 'Hypovolemic shock', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495080, 'HP:0031274', 'Hypovolemic shock', 'MP:0001844', 'autoimmune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495081, 'HP:0031274', 'Hypovolemic shock', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495082, 'HP:0031274', 'Hypovolemic shock', 'MP:0005005', 'abnormal self tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495083, 'HP:0031274', 'Hypovolemic shock', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495084, 'HP:0031274', 'Hypovolemic shock', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495085, 'HP:0031274', 'Hypovolemic shock', 'MP:0002498', 'abnormal acute inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495086, 'HP:0031274', 'Hypovolemic shock', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495087, 'HP:0031274', 'Hypovolemic shock', 'MP:0005671', 'abnormal response to transplant', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495088, 'HP:0031274', 'Hypovolemic shock', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495089, 'HP:0031274', 'Hypovolemic shock', 'MP:0013134', 'poor circulation in autopods', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495090, 'HP:0031274', 'Hypovolemic shock', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495091, 'HP:0031274', 'Hypovolemic shock', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495092, 'HP:0031274', 'Hypovolemic shock', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495093, 'HP:0031274', 'Hypovolemic shock', 'MP:0008748', 'abnormal central T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495094, 'HP:0031274', 'Hypovolemic shock', 'MP:0011953', 'prolonged PQ interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495095, 'HP:0031274', 'Hypovolemic shock', 'MP:0003466', 'decreased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495096, 'HP:0031274', 'Hypovolemic shock', 'MP:0010511', 'shortened PR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495097, 'HP:0031274', 'Hypovolemic shock', 'MP:0003928', 'increased heart rate variability', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495098, 'HP:0031274', 'Hypovolemic shock', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495099, 'HP:0031274', 'Hypovolemic shock', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495100, 'HP:0031274', 'Hypovolemic shock', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495101, 'HP:0031274', 'Hypovolemic shock', 'MP:0003900', 'shortened QT interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495102, 'HP:0031274', 'Hypovolemic shock', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495103, 'HP:0031274', 'Hypovolemic shock', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495104, 'HP:0031274', 'Hypovolemic shock', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495105, 'HP:0031274', 'Hypovolemic shock', 'MP:0006110', 'ventricular fibrillation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495106, 'HP:0031274', 'Hypovolemic shock', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495107, 'HP:0031274', 'Hypovolemic shock', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495108, 'HP:0031274', 'Hypovolemic shock', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495109, 'HP:0031274', 'Hypovolemic shock', 'MP:0009698', 'heart hemorrhage', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495110, 'HP:0031274', 'Hypovolemic shock', 'MP:0008776', 'increased right ventricle peak pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495111, 'HP:0031274', 'Hypovolemic shock', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495112, 'HP:0031274', 'Hypovolemic shock', 'MP:0010394', 'decreased QRS amplitude', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495113, 'HP:0031274', 'Hypovolemic shock', 'MP:0011938', 'prolonged PP interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495114, 'HP:0031274', 'Hypovolemic shock', 'MP:0011952', 'decreased cardiac stroke volume', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495115, 'HP:0031274', 'Hypovolemic shock', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495116, 'HP:0031274', 'Hypovolemic shock', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495117, 'HP:0031274', 'Hypovolemic shock', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495118, 'HP:0031274', 'Hypovolemic shock', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495119, 'HP:0031274', 'Hypovolemic shock', 'MP:0003899', 'abnormal QT interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495120, 'HP:0031274', 'Hypovolemic shock', 'MP:0001752', 'abnormal hypothalamus secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495121, 'HP:0031274', 'Hypovolemic shock', 'MP:0002409', 'decreased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495122, 'HP:0031274', 'Hypovolemic shock', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495123, 'HP:0031274', 'Hypovolemic shock', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495124, 'HP:0031274', 'Hypovolemic shock', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495125, 'HP:0031274', 'Hypovolemic shock', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495126, 'HP:0031274', 'Hypovolemic shock', 'MP:0031153', 'stomach hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495127, 'HP:0031274', 'Hypovolemic shock', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495128, 'HP:0031274', 'Hypovolemic shock', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495129, 'HP:0031274', 'Hypovolemic shock', 'MP:0003463', 'abnormal single cell response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495130, 'HP:0031274', 'Hypovolemic shock', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495131, 'HP:0031274', 'Hypovolemic shock', 'MP:0001876', 'decreased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495132, 'HP:0031274', 'Hypovolemic shock', 'MP:0004012', 'increased pulmonary artery pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495133, 'HP:0031274', 'Hypovolemic shock', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495134, 'HP:0031274', 'Hypovolemic shock', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495135, 'HP:0031274', 'Hypovolemic shock', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495136, 'HP:0031274', 'Hypovolemic shock', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495137, 'HP:0031274', 'Hypovolemic shock', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495138, 'HP:0031274', 'Hypovolemic shock', 'MP:0003482', 'increased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495139, 'HP:0031274', 'Hypovolemic shock', 'MP:0021009', 'abnormal synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495140, 'HP:0031274', 'Hypovolemic shock', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495141, 'HP:0031274', 'Hypovolemic shock', 'MP:0003468', 'increased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495142, 'HP:0031274', 'Hypovolemic shock', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495143, 'HP:0031274', 'Hypovolemic shock', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495144, 'HP:0031274', 'Hypovolemic shock', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495145, 'HP:0031274', 'Hypovolemic shock', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495146, 'HP:0031274', 'Hypovolemic shock', 'MP:0001598', 'abnormal blood viscosity', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495147, 'HP:0031274', 'Hypovolemic shock', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495148, 'HP:0031274', 'Hypovolemic shock', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495149, 'HP:0031274', 'Hypovolemic shock', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495150, 'HP:0031274', 'Hypovolemic shock', 'MP:0001636', 'irregular heartbeat', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495151, 'HP:0031274', 'Hypovolemic shock', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495152, 'HP:0031274', 'Hypovolemic shock', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495153, 'HP:0031274', 'Hypovolemic shock', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495154, 'HP:0031274', 'Hypovolemic shock', 'MP:0004086', 'absent heartbeat', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495155, 'HP:0031274', 'Hypovolemic shock', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495156, 'HP:0031274', 'Hypovolemic shock', 'MP:0008744', 'abnormal B cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495157, 'HP:0031274', 'Hypovolemic shock', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495158, 'HP:0031274', 'Hypovolemic shock', 'MP:0004145', 'abnormal muscle electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495159, 'HP:0031274', 'Hypovolemic shock', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495160, 'HP:0031274', 'Hypovolemic shock', 'MP:0004486', 'decreased response of heart to induced stress', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495161, 'HP:0031274', 'Hypovolemic shock', 'MP:0005043', 'defective assembly of class II molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495162, 'HP:0031274', 'Hypovolemic shock', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495163, 'HP:0031274', 'Hypovolemic shock', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495164, 'HP:0031274', 'Hypovolemic shock', 'MP:0013208', 'abnormal cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495165, 'HP:0031274', 'Hypovolemic shock', 'MP:0011954', 'shortened PQ interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495166, 'HP:0031274', 'Hypovolemic shock', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495167, 'HP:0031274', 'Hypovolemic shock', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495168, 'HP:0031274', 'Hypovolemic shock', 'MP:0013171', 'ear hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495169, 'HP:0031274', 'Hypovolemic shock', 'MP:0001917', 'intraventricular hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495170, 'HP:0031274', 'Hypovolemic shock', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495171, 'HP:0031274', 'Hypovolemic shock', 'MP:0012046', 'decreased susceptibility to hypertension', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495172, 'HP:0031274', 'Hypovolemic shock', 'MP:0012045', 'increased susceptibility to hypertension', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495173, 'HP:0031274', 'Hypovolemic shock', 'MP:0002419', 'abnormal innate immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495174, 'HP:0031274', 'Hypovolemic shock', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495175, 'HP:0031274', 'Hypovolemic shock', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495176, 'HP:0031274', 'Hypovolemic shock', 'MP:0005140', 'decreased cardiac muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495177, 'HP:0031274', 'Hypovolemic shock', 'MP:0004879', 'decreased systemic vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495178, 'HP:0031274', 'Hypovolemic shock', 'MP:0000231', 'hypertension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495179, 'HP:0031274', 'Hypovolemic shock', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495180, 'HP:0031274', 'Hypovolemic shock', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495181, 'HP:0031274', 'Hypovolemic shock', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495182, 'HP:0031274', 'Hypovolemic shock', 'MP:0006048', 'pulmonary valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495183, 'HP:0031274', 'Hypovolemic shock', 'MP:0002952', 'ventricular cardiomyopathy', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495184, 'HP:0031274', 'Hypovolemic shock', 'MP:0010559', 'heart block', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495185, 'HP:0031274', 'Hypovolemic shock', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495186, 'HP:0031274', 'Hypovolemic shock', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495187, 'HP:0031274', 'Hypovolemic shock', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495188, 'HP:0031274', 'Hypovolemic shock', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495189, 'HP:0031274', 'Hypovolemic shock', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495190, 'HP:0031274', 'Hypovolemic shock', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495191, 'HP:0031274', 'Hypovolemic shock', 'MP:0006138', 'congestive heart failure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495192, 'HP:0031274', 'Hypovolemic shock', 'MP:0001914', 'hemorrhage', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495193, 'HP:0031274', 'Hypovolemic shock', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495194, 'HP:0031274', 'Hypovolemic shock', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495195, 'HP:0031274', 'Hypovolemic shock', 'MP:0004485', 'increased response of heart to induced stress', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495196, 'HP:0031274', 'Hypovolemic shock', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495197, 'HP:0031274', 'Hypovolemic shock', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495198, 'HP:0031274', 'Hypovolemic shock', 'MP:0010756', 'decreased right ventricle peak pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495199, 'HP:0031274', 'Hypovolemic shock', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495200, 'HP:0031274', 'Hypovolemic shock', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495201, 'HP:0031274', 'Hypovolemic shock', 'MP:0006111', 'abnormal coronary circulation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495202, 'HP:0031274', 'Hypovolemic shock', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495203, 'HP:0031274', 'Hypovolemic shock', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495204, 'HP:0031274', 'Hypovolemic shock', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495205, 'HP:0031274', 'Hypovolemic shock', 'MP:0002406', 'increased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495206, 'HP:0031274', 'Hypovolemic shock', 'MP:0031130', 'right-to-left shunt', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495207, 'HP:0031274', 'Hypovolemic shock', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495208, 'HP:0031274', 'Hypovolemic shock', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495209, 'HP:0031274', 'Hypovolemic shock', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495210, 'HP:0031274', 'Hypovolemic shock', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495211, 'HP:0031274', 'Hypovolemic shock', 'MP:0003038', 'decreased myocardial infarct size', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495212, 'HP:0031274', 'Hypovolemic shock', 'MP:0013135', 'poor circulation in tail', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495213, 'HP:0031274', 'Hypovolemic shock', 'MP:0001837', 'defective assembly of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495214, 'HP:0031274', 'Hypovolemic shock', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495215, 'HP:0031274', 'Hypovolemic shock', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495216, 'HP:0031274', 'Hypovolemic shock', 'MP:0006080', 'brain ischemia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495217, 'HP:0031274', 'Hypovolemic shock', 'MP:0010570', 'prolonged ST segment', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495218, 'HP:0031274', 'Hypovolemic shock', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495219, 'HP:0031274', 'Hypovolemic shock', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495220, 'HP:0031274', 'Hypovolemic shock', 'MP:0002128', 'abnormal blood circulation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495221, 'HP:0031274', 'Hypovolemic shock', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495222, 'HP:0031274', 'Hypovolemic shock', 'MP:0003548', 'pulmonary hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495223, 'HP:0031274', 'Hypovolemic shock', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495224, 'HP:0031274', 'Hypovolemic shock', 'MP:0031221', 'abnormal CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495225, 'HP:0031274', 'Hypovolemic shock', 'MP:0031109', 'subarachnoid hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495226, 'HP:0031274', 'Hypovolemic shock', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495227, 'HP:0031274', 'Hypovolemic shock', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495228, 'HP:0031274', 'Hypovolemic shock', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495229, 'HP:0031274', 'Hypovolemic shock', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495230, 'HP:0031274', 'Hypovolemic shock', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495231, 'HP:0031274', 'Hypovolemic shock', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495232, 'HP:0031274', 'Hypovolemic shock', 'MP:0001854', 'atrial endocarditis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495233, 'HP:0031274', 'Hypovolemic shock', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495234, 'HP:0031274', 'Hypovolemic shock', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495235, 'HP:0031274', 'Hypovolemic shock', 'MP:0002421', 'abnormal cell-mediated immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495236, 'HP:0031274', 'Hypovolemic shock', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495237, 'HP:0031274', 'Hypovolemic shock', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495238, 'HP:0031274', 'Hypovolemic shock', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495239, 'HP:0031274', 'Hypovolemic shock', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495240, 'HP:0031274', 'Hypovolemic shock', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495241, 'HP:0031274', 'Hypovolemic shock', 'MP:0031154', 'intestinal hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495242, 'HP:0031274', 'Hypovolemic shock', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495243, 'HP:0031274', 'Hypovolemic shock', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495244, 'HP:0031274', 'Hypovolemic shock', 'MP:0006266', 'decreased pulse pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495245, 'HP:0031274', 'Hypovolemic shock', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495246, 'HP:0031274', 'Hypovolemic shock', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495247, 'HP:0031274', 'Hypovolemic shock', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495248, 'HP:0031274', 'Hypovolemic shock', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495249, 'HP:0031274', 'Hypovolemic shock', 'MP:0010552', 'abnormal HV interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495250, 'HP:0031274', 'Hypovolemic shock', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495251, 'HP:0031274', 'Hypovolemic shock', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495252, 'HP:0031274', 'Hypovolemic shock', 'MP:0010514', 'fragmented QRS complex', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495253, 'HP:0031274', 'Hypovolemic shock', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495254, 'HP:0031274', 'Hypovolemic shock', 'MP:0002420', 'abnormal adaptive immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495255, 'HP:0031274', 'Hypovolemic shock', 'MP:0001790', 'abnormal immune system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495256, 'HP:0031274', 'Hypovolemic shock', 'MP:0009276', 'ecchymosis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495257, 'HP:0031274', 'Hypovolemic shock', 'MP:0002723', 'abnormal immune serum protein physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495258, 'HP:0031274', 'Hypovolemic shock', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495259, 'HP:0031274', 'Hypovolemic shock', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495260, 'HP:0031274', 'Hypovolemic shock', 'MP:0021015', 'increased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495261, 'HP:0031274', 'Hypovolemic shock', 'MP:0010631', 'increased Q wave amplitude', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495262, 'HP:0031274', 'Hypovolemic shock', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495263, 'HP:0031274', 'Hypovolemic shock', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495264, 'HP:0031274', 'Hypovolemic shock', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495265, 'HP:0031274', 'Hypovolemic shock', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495266, 'HP:0031274', 'Hypovolemic shock', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495267, 'HP:0031274', 'Hypovolemic shock', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495268, 'HP:0031274', 'Hypovolemic shock', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495269, 'HP:0031274', 'Hypovolemic shock', 'MP:0001596', 'hypotension', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495270, 'HP:0031274', 'Hypovolemic shock', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495271, 'HP:0031274', 'Hypovolemic shock', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495272, 'HP:0031274', 'Hypovolemic shock', 'MP:0031302', 'syncope', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495273, 'HP:0031274', 'Hypovolemic shock', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495274, 'HP:0031274', 'Hypovolemic shock', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495275, 'HP:0031274', 'Hypovolemic shock', 'MP:0004010', 'increased diastolic filling velocity', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495276, 'HP:0031274', 'Hypovolemic shock', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495277, 'HP:0031274', 'Hypovolemic shock', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495278, 'HP:0031274', 'Hypovolemic shock', 'MP:0001633', 'poor circulation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495279, 'HP:0031274', 'Hypovolemic shock', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495280, 'HP:0031274', 'Hypovolemic shock', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495281, 'HP:0031274', 'Hypovolemic shock', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495282, 'HP:0031274', 'Hypovolemic shock', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495283, 'HP:0031274', 'Hypovolemic shock', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495284, 'HP:0031274', 'Hypovolemic shock', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495285, 'HP:0031274', 'Hypovolemic shock', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495286, 'HP:0031274', 'Hypovolemic shock', 'MP:0031155', 'small intestine hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495287, 'HP:0031274', 'Hypovolemic shock', 'MP:0006049', 'semilunar valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495288, 'HP:0031274', 'Hypovolemic shock', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495289, 'HP:0031274', 'Hypovolemic shock', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495290, 'HP:0031274', 'Hypovolemic shock', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495291, 'HP:0031274', 'Hypovolemic shock', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495292, 'HP:0031274', 'Hypovolemic shock', 'MP:0009275', 'bruising', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495293, 'HP:0031274', 'Hypovolemic shock', 'MP:0001629', 'abnormal heart rate', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495294, 'HP:0031274', 'Hypovolemic shock', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495295, 'HP:0031274', 'Hypovolemic shock', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495296, 'HP:0031274', 'Hypovolemic shock', 'MP:0006203', 'eye hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495297, 'HP:0031274', 'Hypovolemic shock', 'MP:0010520', 'sinoatrial block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495298, 'HP:0031274', 'Hypovolemic shock', 'MP:0005001', 'abnormal clonal deletion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495299, 'HP:0031274', 'Hypovolemic shock', 'MP:0008555', 'abnormal interferon secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495300, 'HP:0031274', 'Hypovolemic shock', 'MP:0003880', 'abnormal central pattern generator function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495301, 'HP:0031274', 'Hypovolemic shock', 'MP:0008747', 'abnormal T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495302, 'HP:0031274', 'Hypovolemic shock', 'MP:0000233', 'abnormal blood flow velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495303, 'HP:0031274', 'Hypovolemic shock', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495304, 'HP:0031274', 'Hypovolemic shock', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495305, 'HP:0031274', 'Hypovolemic shock', 'MP:0001916', 'intracerebral hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495306, 'HP:0031274', 'Hypovolemic shock', 'MP:0000343', 'abnormal response to cardiac infarction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495307, 'HP:0031274', 'Hypovolemic shock', 'MP:0004994', 'abnormal brain wave pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495308, 'HP:0031274', 'Hypovolemic shock', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495309, 'HP:0031274', 'Hypovolemic shock', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495310, 'HP:0031274', 'Hypovolemic shock', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495311, 'HP:0031274', 'Hypovolemic shock', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495312, 'HP:0031274', 'Hypovolemic shock', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495313, 'HP:0031274', 'Hypovolemic shock', 'MP:0008558', 'abnormal interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495314, 'HP:0031274', 'Hypovolemic shock', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495315, 'HP:0031274', 'Hypovolemic shock', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495316, 'HP:0031274', 'Hypovolemic shock', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495317, 'HP:0031274', 'Hypovolemic shock', 'MP:0002842', 'increased systemic arterial blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495318, 'HP:0031274', 'Hypovolemic shock', 'MP:0003549', 'pulmonary hypotension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495319, 'HP:0031274', 'Hypovolemic shock', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495320, 'HP:0031274', 'Hypovolemic shock', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495321, 'HP:0031274', 'Hypovolemic shock', 'MP:0002472', 'impaired complement alternative pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495322, 'HP:0031274', 'Hypovolemic shock', 'MP:0010515', 'abnormal Q wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495323, 'HP:0031274', 'Hypovolemic shock', 'MP:0031117', 'subdural hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495324, 'HP:0031274', 'Hypovolemic shock', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495325, 'HP:0031274', 'Hypovolemic shock', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495326, 'HP:0031274', 'Hypovolemic shock', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495327, 'HP:0031274', 'Hypovolemic shock', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495328, 'HP:0031274', 'Hypovolemic shock', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495329, 'HP:0031274', 'Hypovolemic shock', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495330, 'HP:0031274', 'Hypovolemic shock', 'MP:0010634', 'increased QRS amplitude', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495331, 'HP:0031274', 'Hypovolemic shock', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495332, 'HP:0031274', 'Hypovolemic shock', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495333, 'HP:0031274', 'Hypovolemic shock', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495334, 'HP:0031274', 'Hypovolemic shock', 'MP:0011951', 'increased cardiac stroke volume', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495335, 'HP:0031274', 'Hypovolemic shock', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495336, 'HP:0031274', 'Hypovolemic shock', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495337, 'HP:0031274', 'Hypovolemic shock', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495338, 'HP:0031274', 'Hypovolemic shock', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495339, 'HP:0031274', 'Hypovolemic shock', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495340, 'HP:0031274', 'Hypovolemic shock', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495341, 'HP:0031274', 'Hypovolemic shock', 'MP:0001915', 'intracranial hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495342, 'HP:0031274', 'Hypovolemic shock', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495343, 'HP:0031274', 'Hypovolemic shock', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495344, 'HP:0031274', 'Hypovolemic shock', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495345, 'HP:0031274', 'Hypovolemic shock', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495346, 'HP:0031274', 'Hypovolemic shock', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495347, 'HP:0031274', 'Hypovolemic shock', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495348, 'HP:0031274', 'Hypovolemic shock', 'MP:0004039', 'abnormal cardiac cell glucose uptake', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495349, 'HP:0031274', 'Hypovolemic shock', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495350, 'HP:0031274', 'Hypovolemic shock', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495351, 'HP:0031274', 'Hypovolemic shock', 'MP:0005025', 'abnormal response to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495352, 'HP:0031274', 'Hypovolemic shock', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495353, 'HP:0031274', 'Hypovolemic shock', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495354, 'HP:0031274', 'Hypovolemic shock', 'MP:0011936', 'abnormal PP interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495355, 'HP:0031274', 'Hypovolemic shock', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495356, 'HP:0031274', 'Hypovolemic shock', 'MP:0003896', 'prolonged PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495357, 'HP:0031274', 'Hypovolemic shock', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495358, 'HP:0031274', 'Hypovolemic shock', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495359, 'HP:0031274', 'Hypovolemic shock', 'MP:0021053', 'abnormal renal arterial blood pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495360, 'HP:0031274', 'Hypovolemic shock', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495361, 'HP:0031274', 'Hypovolemic shock', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495362, 'HP:0031274', 'Hypovolemic shock', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495363, 'HP:0031274', 'Hypovolemic shock', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495364, 'HP:0031274', 'Hypovolemic shock', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495365, 'HP:0031274', 'Hypovolemic shock', 'MP:0003473', 'decreased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495366, 'HP:0031274', 'Hypovolemic shock', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495367, 'HP:0031274', 'Hypovolemic shock', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495368, 'HP:0031274', 'Hypovolemic shock', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495369, 'HP:0031274', 'Hypovolemic shock', 'MP:0003475', 'increased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495370, 'HP:0031274', 'Hypovolemic shock', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495371, 'HP:0031274', 'Hypovolemic shock', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495372, 'HP:0031274', 'Hypovolemic shock', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495373, 'HP:0031274', 'Hypovolemic shock', 'MP:0003898', 'abnormal QRS complex', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495374, 'HP:0031274', 'Hypovolemic shock', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495375, 'HP:0031274', 'Hypovolemic shock', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495376, 'HP:0031274', 'Hypovolemic shock', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495377, 'HP:0031274', 'Hypovolemic shock', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495378, 'HP:0031274', 'Hypovolemic shock', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495379, 'HP:0031274', 'Hypovolemic shock', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495380, 'HP:0031274', 'Hypovolemic shock', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495381, 'HP:0031274', 'Hypovolemic shock', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495382, 'HP:0031274', 'Hypovolemic shock', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495383, 'HP:0031274', 'Hypovolemic shock', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495384, 'HP:0031274', 'Hypovolemic shock', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495385, 'HP:0031274', 'Hypovolemic shock', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495386, 'HP:0031274', 'Hypovolemic shock', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495387, 'HP:0031274', 'Hypovolemic shock', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495388, 'HP:0031274', 'Hypovolemic shock', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495389, 'HP:0031274', 'Hypovolemic shock', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495390, 'HP:0031274', 'Hypovolemic shock', 'MP:0004085', 'abnormal heartbeat', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495391, 'HP:0031274', 'Hypovolemic shock', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495392, 'HP:0031274', 'Hypovolemic shock', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495393, 'HP:0031274', 'Hypovolemic shock', 'MP:0009062', 'impaired lectin complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495394, 'HP:0031274', 'Hypovolemic shock', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495395, 'HP:0031274', 'Hypovolemic shock', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495396, 'HP:0031274', 'Hypovolemic shock', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495397, 'HP:0031274', 'Hypovolemic shock', 'MP:0010368', 'abnormal lymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495398, 'HP:0031274', 'Hypovolemic shock', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495399, 'HP:0031274', 'Hypovolemic shock', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495400, 'HP:0031274', 'Hypovolemic shock', 'MP:0010519', 'atrioventricular block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495401, 'HP:0031274', 'Hypovolemic shock', 'MP:0008543', 'atrial fibrillation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495402, 'HP:0031274', 'Hypovolemic shock', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495403, 'HP:0031274', 'Hypovolemic shock', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495404, 'HP:0031274', 'Hypovolemic shock', 'MP:0009384', 'cardiac valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495405, 'HP:0031274', 'Hypovolemic shock', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495406, 'HP:0031274', 'Hypovolemic shock', 'MP:0031192', 'coronary artery spasm', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495407, 'HP:0031274', 'Hypovolemic shock', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495408, 'HP:0031274', 'Hypovolemic shock', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495409, 'HP:0031274', 'Hypovolemic shock', 'MP:0004484', 'abnormal response of heart to induced stress', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495410, 'HP:0031274', 'Hypovolemic shock', 'MP:0010506', 'prolonged RR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495411, 'HP:0031274', 'Hypovolemic shock', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495412, 'HP:0031274', 'Hypovolemic shock', 'MP:0002499', 'chronic inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495413, 'HP:0031274', 'Hypovolemic shock', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495414, 'HP:0031274', 'Hypovolemic shock', 'MP:0020002', 'increased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495415, 'HP:0031274', 'Hypovolemic shock', 'MP:0010512', 'absent PR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495416, 'HP:0031274', 'Hypovolemic shock', 'MP:0020096', 'high mean heart rate adaptation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495417, 'HP:0031274', 'Hypovolemic shock', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495418, 'HP:0031274', 'Hypovolemic shock', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495419, 'HP:0031274', 'Hypovolemic shock', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495420, 'HP:0031274', 'Hypovolemic shock', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495421, 'HP:0031274', 'Hypovolemic shock', 'MP:0004011', 'decreased diastolic filling velocity', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495422, 'HP:0031274', 'Hypovolemic shock', 'MP:0031051', 'lymph node hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495423, 'HP:0031274', 'Hypovolemic shock', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495424, 'HP:0031274', 'Hypovolemic shock', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495425, 'HP:0031274', 'Hypovolemic shock', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495426, 'HP:0031274', 'Hypovolemic shock', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495427, 'HP:0031274', 'Hypovolemic shock', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495428, 'HP:0031274', 'Hypovolemic shock', 'MP:0009732', 'ventricular premature beat', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495429, 'HP:0031274', 'Hypovolemic shock', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495430, 'HP:0031274', 'Hypovolemic shock', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495431, 'HP:0031274', 'Hypovolemic shock', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495432, 'HP:0031274', 'Hypovolemic shock', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495433, 'HP:0031274', 'Hypovolemic shock', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495434, 'HP:0031274', 'Hypovolemic shock', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495435, 'HP:0031274', 'Hypovolemic shock', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495436, 'HP:0031274', 'Hypovolemic shock', 'MP:0003293', 'rectal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495437, 'HP:0031274', 'Hypovolemic shock', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495438, 'HP:0031274', 'Hypovolemic shock', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495439, 'HP:0031274', 'Hypovolemic shock', 'MP:0004245', 'genital hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495440, 'HP:0031274', 'Hypovolemic shock', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495441, 'HP:0031274', 'Hypovolemic shock', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495442, 'HP:0031274', 'Hypovolemic shock', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495443, 'HP:0031274', 'Hypovolemic shock', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495444, 'HP:0031274', 'Hypovolemic shock', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495445, 'HP:0031274', 'Hypovolemic shock', 'MP:0001845', 'abnormal inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495446, 'HP:0031274', 'Hypovolemic shock', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495447, 'HP:0031274', 'Hypovolemic shock', 'MP:0000951', 'sporadic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495448, 'HP:0031274', 'Hypovolemic shock', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495449, 'HP:0031274', 'Hypovolemic shock', 'MP:0005044', 'sepsis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495450, 'HP:0031274', 'Hypovolemic shock', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495451, 'HP:0031274', 'Hypovolemic shock', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495452, 'HP:0031274', 'Hypovolemic shock', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495453, 'HP:0031274', 'Hypovolemic shock', 'MP:0003472', 'increased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495454, 'HP:0031274', 'Hypovolemic shock', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495455, 'HP:0031274', 'Hypovolemic shock', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495456, 'HP:0031274', 'Hypovolemic shock', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495457, 'HP:0031274', 'Hypovolemic shock', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495458, 'HP:0031274', 'Hypovolemic shock', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495459, 'HP:0031274', 'Hypovolemic shock', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495460, 'HP:0031274', 'Hypovolemic shock', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495461, 'HP:0031274', 'Hypovolemic shock', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495462, 'HP:0031274', 'Hypovolemic shock', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495463, 'HP:0031274', 'Hypovolemic shock', 'MP:0001857', 'pericarditis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495464, 'HP:0031274', 'Hypovolemic shock', 'MP:0001856', 'myocarditis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495465, 'HP:0031274', 'Hypovolemic shock', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495466, 'HP:0031274', 'Hypovolemic shock', 'MP:0011994', 'increased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495467, 'HP:0031274', 'Hypovolemic shock', 'MP:0004217', 'salt-sensitive hypertension', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495468, 'HP:0031274', 'Hypovolemic shock', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495469, 'HP:0031274', 'Hypovolemic shock', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495470, 'HP:0031274', 'Hypovolemic shock', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495471, 'HP:0031274', 'Hypovolemic shock', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495472, 'HP:0031274', 'Hypovolemic shock', 'MP:0008814', 'decreased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495473, 'HP:0031274', 'Hypovolemic shock', 'MP:0005598', 'decreased ventricle muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495474, 'HP:0031274', 'Hypovolemic shock', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495475, 'HP:0031274', 'Hypovolemic shock', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495476, 'HP:0031274', 'Hypovolemic shock', 'MP:0003897', 'abnormal ST segment', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495477, 'HP:0031274', 'Hypovolemic shock', 'MP:0003393', 'decreased cardiac output', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495478, 'HP:0031274', 'Hypovolemic shock', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495479, 'HP:0031274', 'Hypovolemic shock', 'MP:0011920', 'abnormal S wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495480, 'HP:0031274', 'Hypovolemic shock', 'MP:0003823', 'increased left ventricle developed pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495481, 'HP:0031274', 'Hypovolemic shock', 'MP:0020418', 'increased cardiac muscle relaxation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495482, 'HP:0031274', 'Hypovolemic shock', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495483, 'HP:0031274', 'Hypovolemic shock', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495484, 'HP:0031274', 'Hypovolemic shock', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495485, 'HP:0031274', 'Hypovolemic shock', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495486, 'HP:0031274', 'Hypovolemic shock', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495487, 'HP:0031274', 'Hypovolemic shock', 'MP:0005088', 'increased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495488, 'HP:0031274', 'Hypovolemic shock', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495489, 'HP:0031274', 'Hypovolemic shock', 'MP:0003037', 'increased myocardial infarct size', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495490, 'HP:0031274', 'Hypovolemic shock', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495491, 'HP:0031274', 'Hypovolemic shock', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495492, 'HP:0031274', 'Hypovolemic shock', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495493, 'HP:0031274', 'Hypovolemic shock', 'MP:0010637', 'sinus bradycardia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495494, 'HP:0031274', 'Hypovolemic shock', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495495, 'HP:0031274', 'Hypovolemic shock', 'MP:0004752', 'decreased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495496, 'HP:0031274', 'Hypovolemic shock', 'MP:0010516', 'absent Q wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495497, 'HP:0031274', 'Hypovolemic shock', 'MP:0011928', 'abnormal mitral valve flow', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495498, 'HP:0031274', 'Hypovolemic shock', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495499, 'HP:0031274', 'Hypovolemic shock', 'MP:0010753', 'improved mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495500, 'HP:0031274', 'Hypovolemic shock', 'MP:0020154', 'impaired humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495501, 'HP:0031274', 'Hypovolemic shock', 'MP:0001634', 'internal hemorrhage', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495502, 'HP:0031274', 'Hypovolemic shock', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495503, 'HP:0031274', 'Hypovolemic shock', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495504, 'HP:0031274', 'Hypovolemic shock', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495505, 'HP:0031274', 'Hypovolemic shock', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495506, 'HP:0031274', 'Hypovolemic shock', 'MP:0010392', 'prolonged QRS complex duration', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495507, 'HP:0031274', 'Hypovolemic shock', 'MP:0000304', 'abnormal cardiac stroke volume', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495508, 'HP:0031274', 'Hypovolemic shock', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495509, 'HP:0031274', 'Hypovolemic shock', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495510, 'HP:0031274', 'Hypovolemic shock', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495511, 'HP:0031274', 'Hypovolemic shock', 'MP:0004122', 'abnormal sinus arrhythmia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495512, 'HP:0031274', 'Hypovolemic shock', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495513, 'HP:0031274', 'Hypovolemic shock', 'MP:0006046', 'atrioventricular valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495514, 'HP:0031274', 'Hypovolemic shock', 'MP:0010510', 'absent P wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495515, 'HP:0031274', 'Hypovolemic shock', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495516, 'HP:0031274', 'Hypovolemic shock', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495517, 'HP:0031274', 'Hypovolemic shock', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495518, 'HP:0031274', 'Hypovolemic shock', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495519, 'HP:0031274', 'Hypovolemic shock', 'MP:0012006', 'abnormal hippocampus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495520, 'HP:0031274', 'Hypovolemic shock', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495521, 'HP:0031274', 'Hypovolemic shock', 'MP:0002626', 'increased heart rate', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495522, 'HP:0031274', 'Hypovolemic shock', 'MP:0001864', 'vascular inflammation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495523, 'HP:0031274', 'Hypovolemic shock', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495524, 'HP:0031274', 'Hypovolemic shock', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495525, 'HP:0031274', 'Hypovolemic shock', 'MP:0020000', 'abnormal response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495526, 'HP:0031274', 'Hypovolemic shock', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495527, 'HP:0031274', 'Hypovolemic shock', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495528, 'HP:0031274', 'Hypovolemic shock', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495529, 'HP:0031274', 'Hypovolemic shock', 'MP:0010513', 'abnormal ventricular activation time', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495530, 'HP:0031274', 'Hypovolemic shock', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495531, 'HP:0031274', 'Hypovolemic shock', 'MP:0011927', 'abnormal cardiac valve flow', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495532, 'HP:0031274', 'Hypovolemic shock', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495533, 'HP:0031274', 'Hypovolemic shock', 'MP:0011931', 'abnormal pulmonary valve flow', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495534, 'HP:0031274', 'Hypovolemic shock', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495535, 'HP:0031274', 'Hypovolemic shock', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495536, 'HP:0031274', 'Hypovolemic shock', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495537, 'HP:0031274', 'Hypovolemic shock', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495538, 'HP:0031274', 'Hypovolemic shock', 'MP:0031129', 'left-to-right shunt', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495539, 'HP:0031274', 'Hypovolemic shock', 'MP:0006045', 'mitral valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495540, 'HP:0031274', 'Hypovolemic shock', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495541, 'HP:0031274', 'Hypovolemic shock', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495542, 'HP:0031274', 'Hypovolemic shock', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495543, 'HP:0031274', 'Hypovolemic shock', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495544, 'HP:0031274', 'Hypovolemic shock', 'MP:0004072', 'abnormal frontal plane axis', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495545, 'HP:0031274', 'Hypovolemic shock', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495546, 'HP:0031274', 'Hypovolemic shock', 'MP:0030132', 'periodontium inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495547, 'HP:0031274', 'Hypovolemic shock', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495548, 'HP:0031274', 'Hypovolemic shock', 'MP:0003659', 'abnormal lymph circulation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495549, 'HP:0031274', 'Hypovolemic shock', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495550, 'HP:0031274', 'Hypovolemic shock', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495551, 'HP:0031274', 'Hypovolemic shock', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495552, 'HP:0031274', 'Hypovolemic shock', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495553, 'HP:0031274', 'Hypovolemic shock', 'MP:0011919', 'abnormal R wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495554, 'HP:0031274', 'Hypovolemic shock', 'MP:0031471', 'abnormal micropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495555, 'HP:0031274', 'Hypovolemic shock', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495556, 'HP:0031274', 'Hypovolemic shock', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495557, 'HP:0031274', 'Hypovolemic shock', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495558, 'HP:0031274', 'Hypovolemic shock', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495559, 'HP:0031274', 'Hypovolemic shock', 'MP:0006047', 'aortic valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495560, 'HP:0031274', 'Hypovolemic shock', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495561, 'HP:0031274', 'Hypovolemic shock', 'MP:0003929', 'decreased heart rate variability', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495562, 'HP:0031274', 'Hypovolemic shock', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495563, 'HP:0031274', 'Hypovolemic shock', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495564, 'HP:0031274', 'Hypovolemic shock', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495565, 'HP:0031274', 'Hypovolemic shock', 'MP:0001793', 'abnormal susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495566, 'HP:0031274', 'Hypovolemic shock', 'MP:0003889', 'enhanced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495567, 'HP:0031274', 'Hypovolemic shock', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495568, 'HP:0031274', 'Hypovolemic shock', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495569, 'HP:0031274', 'Hypovolemic shock', 'MP:0003470', 'abnormal summary potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495570, 'HP:0031274', 'Hypovolemic shock', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495571, 'HP:0031274', 'Hypovolemic shock', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495572, 'HP:0031274', 'Hypovolemic shock', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495573, 'HP:0031274', 'Hypovolemic shock', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495574, 'HP:0031274', 'Hypovolemic shock', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495575, 'HP:0031274', 'Hypovolemic shock', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495576, 'HP:0031274', 'Hypovolemic shock', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495577, 'HP:0031274', 'Hypovolemic shock', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495578, 'HP:0031274', 'Hypovolemic shock', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495579, 'HP:0031274', 'Hypovolemic shock', 'MP:0006052', 'cerebellum hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495580, 'HP:0031274', 'Hypovolemic shock', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495581, 'HP:0031274', 'Hypovolemic shock', 'MP:0003633', 'abnormal nervous system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495582, 'HP:0031274', 'Hypovolemic shock', 'MP:0003882', 'abnormal pulse pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495583, 'HP:0031274', 'Hypovolemic shock', 'MP:0006054', 'spinal hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495584, 'HP:0031274', 'Hypovolemic shock', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495585, 'HP:0031274', 'Hypovolemic shock', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495586, 'HP:0031274', 'Hypovolemic shock', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495587, 'HP:0031274', 'Hypovolemic shock', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495588, 'HP:0031274', 'Hypovolemic shock', 'MP:0004071', 'prolonged P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495589, 'HP:0031274', 'Hypovolemic shock', 'MP:0003481', 'decreased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495590, 'HP:0031274', 'Hypovolemic shock', 'MP:0011937', 'shortened PP interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495591, 'HP:0031274', 'Hypovolemic shock', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495592, 'HP:0031274', 'Hypovolemic shock', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495593, 'HP:0031274', 'Hypovolemic shock', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495594, 'HP:0031274', 'Hypovolemic shock', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495595, 'HP:0031274', 'Hypovolemic shock', 'MP:0010571', 'shortened ST segment', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495596, 'HP:0031274', 'Hypovolemic shock', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495597, 'HP:0031274', 'Hypovolemic shock', 'MP:0031136', 'muscle hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495598, 'HP:0031274', 'Hypovolemic shock', 'MP:0012554', 'increased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495599, 'HP:0031274', 'Hypovolemic shock', 'MP:0003480', 'increased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495600, 'HP:0031274', 'Hypovolemic shock', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495601, 'HP:0031274', 'Hypovolemic shock', 'MP:0020155', 'enhanced humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495602, 'HP:0031274', 'Hypovolemic shock', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495603, 'HP:0031274', 'Hypovolemic shock', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495604, 'HP:0031274', 'Hypovolemic shock', 'MP:0005245', 'hemarthrosis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495605, 'HP:0031274', 'Hypovolemic shock', 'MP:0014120', 'focal seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495606, 'HP:0031274', 'Hypovolemic shock', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495607, 'HP:0031274', 'Hypovolemic shock', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495608, 'HP:0031274', 'Hypovolemic shock', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495609, 'HP:0031274', 'Hypovolemic shock', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495610, 'HP:0031274', 'Hypovolemic shock', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495611, 'HP:0031274', 'Hypovolemic shock', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495612, 'HP:0031274', 'Hypovolemic shock', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495613, 'HP:0031274', 'Hypovolemic shock', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495614, 'HP:0031274', 'Hypovolemic shock', 'MP:0010636', 'bundle branch block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495615, 'HP:0031274', 'Hypovolemic shock', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495616, 'HP:0031274', 'Hypovolemic shock', 'MP:0004120', 'cardiac ischemia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495617, 'HP:0031274', 'Hypovolemic shock', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495618, 'HP:0031274', 'Hypovolemic shock', 'MP:0010504', 'abnormal RR interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495619, 'HP:0031274', 'Hypovolemic shock', 'MP:0012565', 'perivasculitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495620, 'HP:0031274', 'Hypovolemic shock', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495621, 'HP:0031274', 'Hypovolemic shock', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495622, 'HP:0031274', 'Hypovolemic shock', 'MP:0000948', 'nonconvulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495623, 'HP:0031274', 'Hypovolemic shock', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495624, 'HP:0031274', 'Hypovolemic shock', 'MP:0003034', 'increased pulmonary vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(495625, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495626, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495627, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495628, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495629, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495630, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495631, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495632, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495633, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495634, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495635, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495636, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495637, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495638, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495639, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495640, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495641, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495642, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495643, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495644, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495645, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495646, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495647, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495648, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495649, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495650, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495651, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495652, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495653, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495654, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495655, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495656, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495657, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495658, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495659, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495660, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495661, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495662, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495663, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495664, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495665, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495666, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495667, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495668, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495669, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495670, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495671, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495672, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495673, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495674, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495675, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495676, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495677, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495678, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495679, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495680, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495681, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495682, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495683, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495684, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495685, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495686, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495687, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495688, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495689, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495690, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495691, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495692, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495693, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495694, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495695, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495696, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495697, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495698, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495699, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495700, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495701, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495702, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495703, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495704, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495705, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495706, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495707, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495708, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495709, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495710, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495711, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495712, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495713, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495714, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495715, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495716, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495717, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495718, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495719, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495720, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495721, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495722, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495723, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495724, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495725, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495726, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495727, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495728, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495729, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495730, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495731, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495732, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495733, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495734, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495735, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495736, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495737, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495738, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495739, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495740, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495741, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495742, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495743, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495744, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495745, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495746, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495747, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495748, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495749, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495750, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495751, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495752, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495753, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495754, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495755, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495756, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495757, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495758, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495759, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495760, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495761, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495762, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495763, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495764, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495765, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495766, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495767, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495768, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495769, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495770, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495771, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495772, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495773, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495774, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495775, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495776, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495777, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495778, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495779, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495780, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495781, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495782, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495783, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495784, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495785, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495786, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495787, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495788, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495789, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495790, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495791, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495792, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495793, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495794, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495795, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495796, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495797, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495798, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495799, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495800, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495801, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495802, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495803, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495804, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495805, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495806, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495807, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495808, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495809, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495810, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495811, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495812, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495813, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495814, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495815, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495816, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495817, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495818, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495819, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495820, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495821, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495822, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495823, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495824, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495825, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495826, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495827, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495828, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495829, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495830, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495831, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495832, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495833, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495834, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495835, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495836, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495837, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495838, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495839, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495840, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495841, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495842, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495843, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495844, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495845, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495846, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495847, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495848, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495849, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495850, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495851, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495852, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495853, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495854, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495855, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495856, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495857, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495858, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495859, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495860, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495861, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495862, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495863, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495864, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495865, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495866, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495867, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495868, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495869, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495870, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495871, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495872, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495873, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495874, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495875, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495876, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495877, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495878, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495879, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495880, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495881, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495882, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495883, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495884, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495885, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495886, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495887, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495888, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495889, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495890, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495891, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495892, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495893, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495894, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495895, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495896, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495897, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495898, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495899, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495900, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495901, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495902, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495903, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495904, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495905, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495906, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495907, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495908, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495909, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495910, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495911, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495912, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495913, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495914, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495915, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495916, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495917, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495918, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495919, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495920, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495921, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495922, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495923, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495924, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495925, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495926, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495927, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495928, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495929, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495930, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495931, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495932, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495933, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495934, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495935, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495936, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495937, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495938, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495939, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495940, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495941, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495942, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495943, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495944, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495945, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495946, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495947, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495948, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495949, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495950, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495951, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495952, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495953, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495954, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495955, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495956, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495957, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495958, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495959, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495960, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495961, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495962, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495963, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495964, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495965, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495966, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495967, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495968, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495969, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495970, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495971, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495972, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495973, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495974, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495975, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495976, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495977, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495978, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495979, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495980, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495981, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495982, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495983, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495984, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495985, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495986, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495987, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495988, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495989, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495990, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495991, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495992, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495993, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495994, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495995, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495996, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495997, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(495998, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(495999, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496000, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(496001, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(496002, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(496003, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(496004, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496005, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496006, 'HP:0045043', 'Decreased circulating complement C4a concentration', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496007, 'HP:0008742', 'Prominent prostate median bar', 'MP:0031209', 'enlarged cauda epididymis', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496008, 'HP:0008742', 'Prominent prostate median bar', 'MP:0009207', 'internal male genitalia hypoplasia', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496009, 'HP:0008742', 'Prominent prostate median bar', 'MP:0031211', 'small corpus epididymis', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496010, 'HP:0008742', 'Prominent prostate median bar', 'MP:0009256', 'enlarged corpus epididymis', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496011, 'HP:0008742', 'Prominent prostate median bar', 'MP:0009205', 'abnormal internal male genitalia morphology', 0.4358974358974359, 10.371930806217245, 2.1262873850295314, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496012, 'HP:0008742', 'Prominent prostate median bar', 'MP:0004931', 'enlarged epididymis', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496013, 'HP:0008742', 'Prominent prostate median bar', 'MP:0009140', 'dilated efferent ductule of testis', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496014, 'HP:0008742', 'Prominent prostate median bar', 'MP:0014187', 'spermatocele', 0.425, 10.371930806217245, 2.0995405670389724, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496015, 'HP:0008742', 'Prominent prostate median bar', 'MP:0004927', 'abnormal epididymis weight', 0.425531914893617, 10.371930806217245, 2.1008540113757834, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496016, 'HP:0008742', 'Prominent prostate median bar', 'MP:0031210', 'small cauda epididymis', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496017, 'HP:0008742', 'Prominent prostate median bar', 'MP:0004728', 'abnormal efferent ductules of testis morphology', 0.4146341463414634, 10.371930806217245, 2.0737783574308546, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496018, 'HP:0008742', 'Prominent prostate median bar', 'MP:0010145', 'abnormal spermatic cord morphology', 0.4146341463414634, 10.371930806217245, 2.0737783574308546, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496019, 'HP:0008742', 'Prominent prostate median bar', 'MP:0004926', 'abnormal epididymis size', 0.45454545454545453, 10.371930806217245, 2.1712931637220296, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496020, 'HP:0008742', 'Prominent prostate median bar', 'MP:0009249', 'enlarged caput epididymis', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496021, 'HP:0008742', 'Prominent prostate median bar', 'MP:0014188', 'epididymis fibrosis', 0.45454545454545453, 10.371930806217245, 2.1712931637220296, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496022, 'HP:0008742', 'Prominent prostate median bar', 'MP:0004934', 'epididymis epithelium degeneration', 0.40816326530612246, 10.371930806217245, 2.0575327811227684, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496023, 'HP:0008742', 'Prominent prostate median bar', 'MP:0004930', 'small epididymis', 0.4166666666666667, 10.371930806217245, 2.078854933833492, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496024, 'HP:0008742', 'Prominent prostate median bar', 'MP:0004935', 'epididymis degeneration', 0.4444444444444444, 10.371930806217245, 2.147032143444863, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496025, 'HP:0008742', 'Prominent prostate median bar', 'MP:0002631', 'abnormal epididymis morphology', 0.4146341463414634, 10.371930806217245, 2.0737783574308546, 'UPHENO:0087645', 'abnormal internal male genitalia morphology'),
(496026, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0001312', 'abnormal cornea morphology', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496027, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0031432', 'cornea perforation', 0.4727272727272727, 11.115294171581601, 2.292270206431415, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496028, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0004284', 'abnormal Descemet membrane morphology', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496029, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0012121', 'sclerocornea', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496030, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0011961', 'abnormal cornea thickness', 0.4482758620689655, 11.115294171581601, 2.2322002770620495, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496031, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0008521', 'abnormal Bowman membrane morphology', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496032, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0006225', 'ocular rupture', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(496033, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0006000', 'abnormal corneal epithelium morphology', 0.4339622641509434, 12.906707549770184, 2.3666482693954216, 'UPHENO:0088041', 'abnormal corneal epithelium morphology'),
(496034, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0031498', 'abnormal cornea size', 0.4727272727272727, 11.115294171581601, 2.292270206431415, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496035, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0012351', 'cornea degeneration', 0.4642857142857143, 11.115294171581601, 2.2717113139544383, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496036, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0031499', 'decreased cornea size', 0.4406779661016949, 11.115294171581601, 2.213202482411992, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496037, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0001306', 'small lens', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(496038, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0002697', 'abnormal eye size', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(496039, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0012353', 'bilateral cornea degeneration', 0.45614035087719296, 11.115294171581601, 2.2516958461409593, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496040, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0020859', 'disorganized corneal epithelium', 0.48214285714285715, 13.022184767190119, 2.50570416647601, 'UPHENO:0021662', 'abnormal corneal epithelium morphology'),
(496041, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0005300', 'abnormal corneal stroma morphology', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496042, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0009825', 'cornea ulcer', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496043, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0001305', 'enlarged lens', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(496044, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0005301', 'abnormal corneal endothelium morphology', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496045, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0001314', 'corneal opacity', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496046, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0008841', 'ruptured lens capsule', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(496047, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0020858', 'corneal epithelium hypoplasia', 0.43548387096774194, 13.022184767190119, 2.381375953282706, 'UPHENO:0021662', 'abnormal corneal epithelium morphology'),
(496048, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0020855', 'decreased corneal epithelium thickness', 0.43548387096774194, 13.022184767190119, 2.381375953282706, 'UPHENO:0021662', 'abnormal corneal epithelium morphology'),
(496049, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0001307', 'fused cornea and lens', 0.41935483870967744, 11.115294171581601, 2.158993375287247, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496050, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0012352', 'progressive cornea degeneration', 0.45614035087719296, 11.115294171581601, 2.2516958461409593, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496051, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0020854', 'increased corneal epithelium thickness', 0.42857142857142855, 13.022184767190119, 2.36240054368343, 'UPHENO:0021662', 'abnormal corneal epithelium morphology'),
(496052, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0001316', 'corneal scarring', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496053, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0031500', 'increased cornea size', 0.4406779661016949, 11.115294171581601, 2.213202482411992, 'UPHENO:0020998', 'abnormal cornea morphology'),
(496054, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0009742', 'increased corneal stroma thickness', 0.4032258064516129, 10.417322709031257, 2.049520273238552, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496055, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0005544', 'corneal deposits', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496056, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0006209', 'calcified intraocular region', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(496057, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0020853', 'abnormal corneal epithelium thickness', 0.47368421052631576, 13.022184767190119, 2.4836270474397453, 'UPHENO:0021662', 'abnormal corneal epithelium morphology'),
(496058, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0031176', 'abnormal Descemet membrane thickness', 0.423728813559322, 10.417322709031257, 2.100980673866944, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496059, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0014131', 'abnormal tear film morphology', 0.40384615384615385, 9.656834392011628, 1.9748102257035123, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(496060, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0004105', 'corneal abrasion', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(496061, 'HP:0011495', 'Abnormal corneal epithelium morphology', 'MP:0020857', 'corneal epithelium hyperplasia', 0.4576271186440678, 13.022184767190119, 2.441168755629132, 'UPHENO:0021662', 'abnormal corneal epithelium morphology'),
(496062, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496063, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496064, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496065, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496066, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496067, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009142', 'decreased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496068, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496069, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496070, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496071, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496072, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496073, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496074, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496075, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496076, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496077, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496078, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496079, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496080, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496081, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496082, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496083, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496084, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496085, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496086, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496087, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000948', 'nonconvulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496088, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496089, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496090, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496091, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496092, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496093, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496094, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496095, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496096, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496097, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003484', 'abnormal channel response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496098, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496099, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496100, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496101, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496102, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496103, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003473', 'decreased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496104, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009967', 'abnormal neuron proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496105, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496106, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496107, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0014120', 'focal seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496108, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496109, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005402', 'abnormal action potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496110, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496111, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496112, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496113, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496114, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496115, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496116, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496117, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496118, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496119, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496120, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003008', 'enhanced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496121, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496122, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496123, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496124, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496125, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496126, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496127, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496128, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496129, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496130, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496131, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496132, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496133, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496134, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496135, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496136, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010050', 'hypermyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496137, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496138, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496139, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496140, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496141, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496142, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496143, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496144, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496145, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003489', 'increased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496146, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496147, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496148, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496149, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496150, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496151, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496152, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496153, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496154, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496155, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496156, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496157, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496158, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496159, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496160, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496161, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496162, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496163, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496164, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496165, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496166, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496167, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496168, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003996', 'clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496169, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496170, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496171, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496172, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496173, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496174, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496175, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008814', 'decreased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496176, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496177, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496178, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496179, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496180, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496181, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496182, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496183, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013182', 'increased spinal cord apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496184, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496185, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496186, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496187, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496188, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002917', 'decreased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496189, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000920', 'abnormal myelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496190, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000921', 'demyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496191, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496192, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496193, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496194, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496195, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496196, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004859', 'abnormal synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496197, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496198, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496199, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496200, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496201, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496202, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496203, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496204, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496205, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496206, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496207, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496208, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496209, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496210, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496211, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496212, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002923', 'increased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496213, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003490', 'decreased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496214, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006058', 'decreased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496215, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496216, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003477', 'abnormal nerve fiber response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496217, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496218, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496219, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496220, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496221, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496222, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496223, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496224, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003475', 'increased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496225, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496226, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009358', 'environmentally induced seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496227, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496228, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496229, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496230, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496231, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496232, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496233, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496234, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496235, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496236, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496237, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496238, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496239, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496240, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496241, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496242, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496243, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496244, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496245, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496246, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496247, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496248, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496249, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003217', 'increased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496250, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496251, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496252, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496253, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496254, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496255, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496256, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0021001', 'impaired neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496257, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496258, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004994', 'abnormal brain wave pattern', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496259, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496260, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002635', 'reduced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496261, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003469', 'decreased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496262, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496263, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001473', 'reduced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496264, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496265, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496266, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496267, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496268, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496269, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496270, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496271, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496272, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496273, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012006', 'abnormal hippocampus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496274, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496275, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496276, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496277, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002916', 'increased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496278, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496279, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496280, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004768', 'abnormal axonal transport', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496281, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496282, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496283, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496284, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496285, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496286, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496287, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496288, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496289, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496290, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0014179', 'abnormal blood-retina barrier function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496291, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496292, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496293, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496294, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003889', 'enhanced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496295, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496296, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496297, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496298, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496299, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496300, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496301, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496302, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496303, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002914', 'abnormal endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496304, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496305, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496306, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003472', 'increased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496307, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496308, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496309, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496310, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496311, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496312, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0003997', 'tonic-clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(496313, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496314, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496315, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(496316, 'HP:0011973', 'Paroxysmal lethargy', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
